Atlas Trials

Prognostic and Treatment-Response Factors in Metastatic Melanoma: Multi-Center Analysis

Clinical trial NCT07256184 · COMPLETED

Trial details

NCT number
NCT07256184
Sponsor
Ankara Etlik City Hospital
Status
COMPLETED
Study type
OBSERVATIONAL
Metastatic Malignant Melanoma
Start date
2022-11-15
Primary completion
2024-12-15
Enrollment
232

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.